- Previous Rank-
- Revenue 3 Yr Annual Growth Rate18%
- Revenue 3 Yr Growth Rank85
- EPS 3 Yr Annual Growth Rate67%
- EPS 3 Yr Growth Rank21
- Total Return 3 Yr Annual Rate22%
- Total Return 3 Yr Rank55
As complexity grows for clinical trials and studies, Medidata, which makes cloud-based software to help automate them, is profiting handsomely.
Looking for leads, investment insights, or competitive intelligence?Buy Now
Company Information
| Location | New York, N.Y. |
| Industry | Health Care: Pharmacy and Other Services |
| Sector | Health Care |
| Current Streak | - |
| Years on List | 1 |
| CEO | Tarek Sherif |
| Website | http://www.mdsol.com |
Revenue and net income for the four quarters ended on or before April 30, 2017. Total return for the period ended June 30, 2017.
Revenue, Net Income
| Revenue past four quarters ($M) | $486 |
| Net Income past four quarters ($M) | $34 |
Growth Rates and Ranks
| Revenue 3 Yr Growth Rank | 85 |
| Revenue 3 Yr Annual Growth Rate | 18% |
| EPS 3 Yr Growth Rank | 21 |
| EPS 3 Yr Annual Growth Rate | 67% |
| Total Return 3 Yr Rank | 55 |
| Total Return 3 Yr Annual Rate | 22% |
| Beat S&P 500 (9.6%) | yes |
| P/E Ratio | 99 |